Artini, M.; Imperlini, E.; Buonocore, F.; Relucenti, M.; Porcelli, F.; Donfrancesco, O.; Tuccio Guarna Assanti, V.; Fiscarelli, E.V.; Papa, R.; Selan, L.
Anti-Virulence Potential of a Chionodracine-Derived Peptide against Multidrug-Resistant Pseudomonas aeruginosa Clinical Isolates from Cystic Fibrosis Patients. Int. J. Mol. Sci. 2022, 23, 13494.
https://doi.org/10.3390/ijms232113494
AMA Style
Artini M, Imperlini E, Buonocore F, Relucenti M, Porcelli F, Donfrancesco O, Tuccio Guarna Assanti V, Fiscarelli EV, Papa R, Selan L.
Anti-Virulence Potential of a Chionodracine-Derived Peptide against Multidrug-Resistant Pseudomonas aeruginosa Clinical Isolates from Cystic Fibrosis Patients. International Journal of Molecular Sciences. 2022; 23(21):13494.
https://doi.org/10.3390/ijms232113494
Chicago/Turabian Style
Artini, Marco, Esther Imperlini, Francesco Buonocore, Michela Relucenti, Fernando Porcelli, Orlando Donfrancesco, Vanessa Tuccio Guarna Assanti, Ersilia Vita Fiscarelli, Rosanna Papa, and Laura Selan.
2022. "Anti-Virulence Potential of a Chionodracine-Derived Peptide against Multidrug-Resistant Pseudomonas aeruginosa Clinical Isolates from Cystic Fibrosis Patients" International Journal of Molecular Sciences 23, no. 21: 13494.
https://doi.org/10.3390/ijms232113494
APA Style
Artini, M., Imperlini, E., Buonocore, F., Relucenti, M., Porcelli, F., Donfrancesco, O., Tuccio Guarna Assanti, V., Fiscarelli, E. V., Papa, R., & Selan, L.
(2022). Anti-Virulence Potential of a Chionodracine-Derived Peptide against Multidrug-Resistant Pseudomonas aeruginosa Clinical Isolates from Cystic Fibrosis Patients. International Journal of Molecular Sciences, 23(21), 13494.
https://doi.org/10.3390/ijms232113494